Thus, the TLR4/NF-κB signaling pathway plays an important role in NAFLD progression and, consistent with previous findings, regulates the expression of IL-6 and TNF-α, key factors involved in NAFLD development. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.